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Introduction: Individuals with Substance Use Disorder (SUD) often have cognitive
deficits in multiple domains, including motor timing deficits, with recovery times of up to 1
year. Cognitive deficits influence treatment outcomes and abstinence. To our knowledge,
timing deficits have not been investigated with regard to treatment outcome and relapse.
Methods: This prospective study tested the prognostic value of motor timing in SUD
with regard to treatment outcome. The study sample consisted of 74 abstinent in-patients
at a private treatment programme for drug/alcohol dependence at the MomentumMental
Healthcare clinic in Somerset West, South Africa, diagnosed with alcohol and/or cocaine
dependence. Participants were tested at three points: (i) Within 72 hours of the start
of the treatment programme (ii) after completion of the treatment programme at 8
weeks (measure of treatment response) through filling out self-report questionnaires
and experimental motor task testing, and (iii) a third visit followed through a telephonic
interview at 12-months (measure of relapse).
Results: Motor timing alone predicted 27 percent of the variance in alcohol
self-efficacy score change, and 25 percent variance in cocaine self-efficacy change
scores at treatment completion. Specifically, spatial errors, synchronization errors and
inter- response interval errors of a spatial tapping task at baseline predicted self-efficacy
in alcohol self-efficacy. Cocaine self-efficacy was predicted by spatial errors and contact
times of a spatial tapping task at very high tempi (300ms) only. The high rate of dropout
at 12 months post-treatment did not allow for further analysis of the prognostic value of
motor timing on relapse.
Conclusions: The results of this investigation show us that motor timing holds
prognostic value with regard to treatment outcomes. Motor timing predictors for relapse
require further investigation going forward.
Keywords: motor timing, prognostic value, temporal cognition, movement, substance use disorder, cocaine,
alcoholism
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INTRODUCTION
Alcohol and cocaine are amongst the most widely
abused substances (The Global Drug Survey 2015 Findings,
2015). Chronic exposure to substances leads to structural and
functional brain disturbances (Moselhy et al., 2001; Oscar-
Berman and Marinkovic, 2003; Scheurich, 2005; Verdejo-García
et al., 2007; Volkow et al., 2010; Bühler and Mann, 2011), which
underlie the cognitive decline and behavioral changes found
in Substance Use Disorder (SUD) (Miller, 1991; Bates et al.,
2002; Goldstein and Volkow, 2011). Recent studies on the
neurocognitive effects of long-term substances of abuse show
that, instead of specific impairments, dysfunctions occur for a
wide array of cognitive domains (Spronk et al., 2013; Stavro et al.,
2013). One such domain is motor timing abilities (Wittmann
et al., 2007). Motor timing is defined as the ability to organize
movement according to temporal structures. One of the few
studies to date that attempted to examine motor timing in
stimulant dependent individuals, whilst controlling for possible
confounds, found that motor timing deficits are present in this
population (Wittmann et al., 2007). The stimulant dependent
group showed abnormal motor timing abilities on all timing
tasks, except sensorimotor synchronization.
The direct influence of these functional deficits on recovery
and sobriety of individuals with SUD remains unclear (Bates
et al., 2002). Long-lasting changes in brain regions are shown to
contribute to relapse, which can occur weeks, months, and even
years after substance use (Welberg, 2011). There are fewmethods
to measure the success of SUD treatment outcomes. Self-efficacy,
is considered an important indicator in the management of SUDs
and in treatment outcome more specifically (Maisto et al., 2000;
Burleson and Kaminer, 2005; Ilgen et al., 2005; Dolan et al.,
2008; Kadden and Litt, 2011), and defined as an individual’s
confidence in his/her ability to abstain from certain adverse
behaviors, such as substance use (Bandura, 1994). Self-efficacy
is seen as an important factor in predicting behavior related to
health, the successful application of coping mechanisms (Tate
et al., 2008), and changing unwanted behavior (Sheeran et al.,
2016). Studies have shown that increased self-efficacy is related to
the ability to suppress habitual responses, a higher level of well-
being, the ability to achieve complete abstinence after treatment,
to apply healthier coping mechanisms, increase participation in
aftercare, predict the duration of abstinence, and decrease the
use of alcohol and other substance use after treatment (Vielva
and Iraurgi, 2001; McKay et al., 2003; Warren et al., 2007;
Tate et al., 2008). Increased levels of self-efficacy at treatment
admission, discharge, and 1 month after treatment was found
to be a strong predictor of prolonged abstinence (Coon et al.,
1998; Ilgen et al., 2005; Dolan et al., 2008; Kadden and Litt,
2011).
Amongst the more objective measures are blood or urine tests.
However, not every treatment setting allows for such measures
to be used in a useful way, requiring compromises to achieve
the most valid outcome possible. In an inpatient treatment
programme, criteria such as abstinence and retention are fulfilled
bymost, if not all inpatients, and are not necessarily an indication
of treatment success or a guarantee of abstinence. In this case a
more subjective measure, such as self-reported belief in the ability
to abstain is an acceptable measure.
In sum, individuals with SUD often have cognitive deficits in
multiple domains, with recovery times of up to 1 year (Spronk
et al., 2013; Stavro et al., 2013). These deficits influence treatment
outcomes and abstinence (Pitel et al., 2007; Fox et al., 2008).
In addition, motor timing deficits have been found in SUD
(Wittmann et al., 2007) but, to our knowledge, timing deficits
have not been investigated with regard to treatment outcomes.
Early detection of motor timing deficits may be predictive
of treatment outcomes. Owing to the limited number of
pharmacological treatment options, many clinicians worldwide
rely solely on psychosocial approaches (Dackis and O’Brien,
2001). Cognitive deficits experienced by individuals with SUD
may, therefore, be of broad relevance in psychosocial adaptation,
and more specialized research that informs clinical practice
and guides future research is needed to improve and broaden
treatment options. This prospective study tested the theoretical
basis for prognostic indicators in SUD with regard to motor
timing (measured in terms of treatment response and relapse).
We expected that (i) the capacity to structure, organize and plan
an action directly toward a visual target [motor reaction task
(Task 1)]; (ii) cognitive control [Go-nogo task (Task 3)]; and (iii)
synchronization abilities [Spatial-tapping task (Task 2)] would
be prognostic of treatment outcome (self-perceived self-efficacy




The study sample consisted of 74 abstinent patients, aged 18–60
years, and diagnosed with alcohol and/or cocaine dependence.
Patients with a primary diagnosis of alcohol and/or cocaine
dependence who were detoxified were included. Patients who
met criteria for other substance abuse (lifetime or current) were
included, provided that these were not their primary drugs
of use/abuse. Patients who met criteria for other substance
dependence (i.e., other than cocaine/alcohol) were excluded. For
the alcohol group, patients were excluded if they had a current
or past history of dependence on cocaine. For the cocaine group,
patients with a current or past history of alcohol dependence were
excluded.
Procedures
Participants were all inpatients at a private treatment programme
for drug/alcohol dependence at a treatment clinic in Somerset
West, South Africa. The clinic offers treatment to individuals
who are mainly of Dutch nationality as the main patient referral
company is situated in the Netherlands. The comprehensive
primary care treatment program, which formed the standard of
care for all participants, centers on an 8-week cycle of treatment
comprising group therapies, individual counseling, written work
and a psycho-educational lecture series. All participants worked
individually with a therapist. A full medical examination was
conducted on every patient included. This consisted of a physical
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examination and toxicology and biochemistry work-up by the
psychiatric nursing staff.
Participants were tested at three points in time: (i)
within 72 hrs of the start of the treatment programme, (ii) after
completion of the treatment programme at 8 weeks (measure of
treatment response), and (iii) at the 12-month follow-up period
(measure of relapse). Designated counselors at the clinic enquired
from patients about their potential interest in participating in the
study. Only participants who gave written consent and who were
eligible upon screening were invited for a first research visit. After
written consent was obtained, participants were enrolled for
participation. Two study visits were conducted at the clinic. Each
of these visits entailed filling out self-report questionnaires and
experimental motor task testing. During baseline assessments
a socio-demographic questionnaire, the Measurements in the
Addictions for Triage and Evaluation.2 (MATE.2.10) (Schippers
et al., 2010), the Mini International Neuropsychiatric Interview
version 5 (MINI 5) (Lecrubier et al., 1997), the Edinburgh
Handedness Questionnaire (EHQ) (Büsch et al., 2010), The
Alcohol Use Disorders Identification Test (AUDIT) (Lundin et al.,
2015), and Drug Use Disorders Identification Test (DUDIT),
(Hildebrand, 2015), the Sheehan Disability Scale (SDS)(Beck
et al., 2004), and the Beck Depression Inventory (BDI) (Beck
et al., 1988), and the Alcohol Abstinence Self-Efficacy Scale
(AASE) and the Cocaine Abstinence Self-Efficacy Scale (CASE)
(DiClemente et al., 1994), the Short Alcohol Withdrawal Scale
(SAWS) (Gossop et al., 2002), and a motor task battery (see
section Temporal Processing: Action-Based Timing Tasks) were
administered. During the second visit (at treatment completion)
the MATE.2.10, SDS, BDI, AASE, CASE were repeated. All
assessments were conducted in a structured manner by either
the principal investigator or a trained research assistant. One
research assistant was appointed for a period of 2 years. For
quality control, all questionnaires and task performance scores,
including data entry, were cross checked by both the PI and
the research assistant. For the administration of all assessments,
standard operating procedures were followed. Task instructions
were read out in the same way to each participant. The same
order of assessment was used for each visit and for each
participant. After completion of the first visit, an appointment
for a second assessment was made. Assessments were undertaken
within 72 hrs of initiation (visit 1) of the treatment program
and repeated at the end of the 8 weeks (last 72 hrs, visit 2). A
telephonic interview using theMATE.2.10 (Schippers et al., 2010)
was administered at 12 months to assess relapse. The research
team did not stay in contact with the patient during the time
between discharge and follow up, due to patient privacy policies
of the clinic. All data were de-identified and kept confidential. In
order to encourage honesty patients were reminded that none of
test results were to be shared with clinical staff.
Measures
Gender, age, handedness, ethnicity, education, family history of
substance dependence, previous admissions/counseling/therapy
history, symptoms of disability, and drug or alcohol usage
(including last intoxication, last drink and last withdrawal),
depression, and psychopathology were assessed with a self-
administered demographic questionnaire, the EHQ (Büsch et al.,
2010), TheMATE.2.10 (Schippers et al., 2010),MINI 5 (Lecrubier
et al., 1997), AUDIT (Lundin et al., 2015), and DUDIT
(Hildebrand, 2015),the SDS (Beck et al., 2004) the BDI (Beck
et al., 1988) and the SAWS (Gossop et al., 2002).
Self-Efficacy
The AASE and CASE (DiClemente et al., 1994) are both self-
report questionnaires consisting of 20 questions that give an
indication of the degree of self-efficacy to abstain from substance
use (i.e., the confidence to abstain from alcohol and / or cocaine).
Items have a 5 point Likert scale ranging from not at all (1)
to very much (5) for example, the level of temptation that a
person experiences to use a substance in a specific situation like
when he/she is concerned about someone. Four subscales can be
distinguished (1) social situations, (2) negative affect, (3) positive
emotions, and (4) physical or other worries (DiClemente et al.,
1994). For a total score, all items are added up and divided by the
number of questions (20).
Temporal Processing: Action-Based Timing Tasks
The motor tasks consisted of a series of reaction-prediction
visuo-motor pointing tasks to measure different aspects of
motor timing (motor sequencing, synchronization, and decision-
making). The sequential pointing tasks were all designed by
Professor Y. Delevoye-Turrell and her team at the University of
Lille, France. These tasks have been used in previous research
but not SUD research, nor in prognostic research of any kind
previously (Delevoye-Turrell et al., 2007, 2012; Dione et al., 2013;
Dione, 2014; Dione and Delevoye-Turrell, 2015). For testing,
participants were seated in a chair in front of a tactile screen (Elo
Touch) of 53 cm by 36 cm by 30 cm. The flat resting screen was
placed horizontally and in close proximity to the participants’
midline in order to avoid muscle fatigue from the repetitive
pointing movements. Visual and auditory signals were controlled
via a PC with coded software in C++. For a detailed overview of
these tasks, please see protocol publication (Young et al., 2016).
Reactivity: the motor reaction task
Motor sequencing abilities were evaluated using a simple finger-
pointing task to visual dots presented on the touch screen.
Participants are required to lift (action initiation- measured
as Reaction Time), and touch (action execution- measured as
Movement Time), one dot (condition one,) a series of two
(condition 2), or three dots (condition 3).
The manipulation of the complexity (the number of dots) of
the motor sequence provided the means to assess lower order
timing mechanisms (one target) and higher order mechanisms
(2 and 3 dots) through the capacity of participants to structure,
organize, and plan an action through time and space by
ensuring accurate pointing in combination with fast movements.
Condition 1 is designed to measure lower order mechanisms
of movement initiation and execution, whereas condition 2 and
3 are designed to measure higher order mechanisms through
increased complexity requiring structuring and planning of
motor timing. Participants are instructed to start with the index
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finger of the dominant hand placed on the square starting zone
which is situated at the bottom left edge of the screen. As soon as
a black dot appears on the screen, the task is to lift off from the
target (square) and touch the target(s) as fast as possible. Three
levels of complexity are counterbalanced: one target, two-target
or three-target conditions.
Synchronization: the spatial-tapping task
With this task, we aimed to evaluate how well self-initiated
actions to external stimuli, present in the environment, are timed
(synchronized) using a Spatial-tapping task (Dione, 2014). This
task measures pointing accuracy in time and space as well as
error in fluency and accuracy. On the tactile screen display are
six black dots 100mm apart in a circle. The task is to touch
each target, one after the other, starting from the bottom right
target, andmoving counter-clockwise using the right index finger
(fist closed). The tempo of the external rhythm is fixed in terms
of inter stimulus interval (ISI) and is considered an important
independent variable in timing research. Each condition is
constituted of a series of sixty taps of, in total, 5 trials (ISI =
1100ms; 700, 500, 400, and 300ms). The total duration of the task
is approximately 10min. In each trial, participants are presented
with an auditory rhythm that must be used to pace their actions.
After listening to the tones for 5.5 s, participants start tapping for
a total trial duration of 35 s. Timing performances on this task
were measured through inter-response interval errors (IRI error)
and synchronization errors (Asynchrony). The IRI was measured
as the time intervals between the start of two successive taps.
The IRI error was then computed as the percentage of absolute
difference between each IRI and the reference ISI of a given
trial. Asynchrony was measured through the difference between
onset of a tap and the time of onset in the external rhythm.
Spatial performances were measured through the measurement
of endpoint distributions of pointing actions and were plotted
as a function of each visual target position. The mean spatial
error (SE) of these spatial ellipses were used as an indication
of spatial performances. The control of pauses was measured
through contact time (CT) and defined as the time of finger
contact with the touch screen. This measure (in ms) was used as
an indicator of the amount of voluntary pauses in the gesture. See
Figure 1 for an overview of how IRI errors, CT, and Asynchrony
were measured.
Cognitive control: the go-nogo task
A modified version of the Go-nogo paradigm was designed to
measure reaction times through a tactile touch of the touch
screen. The starting zone is situated at the bottom left edge of
the screen. The target is a white circle with a black letter or one-
digit black number and participants are instructed to act as fast
as possible (Go) or to refrain from acting (Nogo), depending in
the condition of the task. In the first condition, the task is to
tap the target that appears as fast as possible (100% Go). In the
following blocks, participants are instructed to react and tap the
target as fast as possible, but only if the target is a letter (50% Go).
If the target is a number, they are to refrain from reacting (Nogo).
Numbers and letters were presented in semi-random order. The
targets were presented for 5 s on the screen, with a random
phase lag of ±300ms in order to avoid anticipatory responses.
Cognitive control was measured through decision making (by
measuring reaction times based on the participant’s response
directly after a Go target or after a Nogo target) and adaptability
(by measuring reaction times on responses on targets that came
directly after a Nogo Target Error).
Data Analyses
Backward step-wise regressions were conducted to establish the
best fit of motor timing variables regarding their predictive
power on self-efficacy total score change at 8 weeks. Best subset
regressions were used to select the best fitting models out of the




All participants included in this study completed treatment. All
participants were right handed, (n = 74), 80 percent were male,
and the mean age was 36.6 years old (SD = 10.5, mode = 27,
range 19–60). Forty-two participants (59%) were employed, and
27 participants (36.5%) were receiving unemployment benefits.
Half of the participants were single, 13 participants (20%) were
divorced and 28 participants (40%) had children.
Clinical Characteristics
Patients with comorbid disorders, as assessed on the MINI 5, at
the beginning of their treatment were excluded from entry into
the study; however, at discharge (8 weeks), some participants had
been diagnosed by their treating clinicians, during the course
of treatment, with comorbid disorders (n = 10, 15% Axis 1
Psychiatric disorders; n = 15, 20% Axis II Personality Disorders;
n = 5, 7% both Axis 1 and 2). Previous outpatient treatment
had been attempted unsuccessfully by 38 participants (51.4%)
while 23 participants (31%) had received psychotherapy, 12
participants (16.2%) had previously been admitted to psychiatric
inpatient care (non SUD- majority due to a failed suicide
attempt), and for 21 participants (29%), this was the second
(or more) attempted inpatient rehabilitation. All patients were
detoxified before treatment. However, upon admission, 23 (31%)
of the participants had a positive alcohol test (through a
breathalyzer examination) while 38 participants (54%) had a
positive drug test (cocaine n = 25 (33%), benzodiazepine n = 8
(10.8%), cannabis n = 5 (6.8%), and amphetamine n = 1 (1.4%).
Craving symptoms were minimal at baseline (MATE Q1 cut
off scores of <12 are considered minimal craving) (m = 7.5,
SD= 3.9). Withdrawal symptoms at admission were minimal on
average (m = 8.66, SD = 6.5, Mdn = 7), however a minority
of participants suffered from moderate to severe withdrawal (cut
off score for minimal withdrawal <12, CI = 0;30). Drug use
other than cocaine and/or alcohol was minimal, with 9 percent
using ecstasy, other stimulants (e.g., Speed, Methamphetamine,
15 percent) and sedatives (12 percent) in the 30 days before
admission. The severity of psychiatric comorbid symptoms was
below threshold on the Anxiety, Depression and Stress scale
(MATE Q2 total score of < 60) (m = 41.8, SD = 25.2,
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FIGURE 1 | Viaual overview of inter response interval, inter stimulus interval, asynchrony and contact time. IRI, Inter response interval; ISI, Inter stimulus interval; A,
Asynchrony; CT, Contact Time.
mode= 12). A detailed overview of the clinical and demographic
results can be found in Table 1.
Main Results: Treatment Outcomes
Self-Efficacy to Abstain From Alcohol Use
An overview of the timing task results can be found in Table 2.
A best subset regression analysis of all motor tasks showed that
motor timing deficits at baseline hold prognostic value with
regard to self-efficacy to abstain from alcohol use (R2 = 0.27).
Both the Motor Reaction task and the Go-nogo timing task
were not predictive of self-reported self-efficacy to abstain from
alcohol use. Of the Spatial Tapping Task, SE (at ISI 300ms) at
baseline were predictive of total change in percentages in self-
reported self-efficacy to abstain from alcohol use (b = −0.26,
t(50) =−2.05, p= 0.04). Furthermore, Asynchrony of the Spatial
Tapping Task was found predictive of change in alcohol self-
efficacy scores at discharge. Asynchrony (at ISI 400ms) of the
Spatial Tapping Task at baseline were predictive of total change in
alcohol self-efficacy scores (b = −0.37, t(50) = −2.14, p = 0.03).
IRI of the Spatial Tapping Task were also found to be predictive
of alcohol self-efficacy to abstain from alcohol use at ISI 500ms
intervals (b = −0.28, t(50) = −2.10, p = 0.04) and ISI 700ms
intervals (b = −0.28, t(50) = −2.01, p = 0.04). Although not
statistically significant, Asynchrony and IRI errors of the Spatial
Tapping task at the 1100ms interval conditions occurred in 20
and 17 times, respectively, in the top 20 best predictor models.
Self-Efficacy to Abstain From Cocaine Use
A best subset regression analysis showed that motor timing
deficits at baseline hold prognostic value with regard to self-
efficacy to abstain from cocaine use (R2 = 0.25). Both the Motor
Reaction task and the Go-nogo timing task were not predictive of
self-reported self-efficacy to abstain from cocaine use. SE of the
Spatial Tapping Task at 300ms intervals (b=−0.31, t(50) = 2.62,
p= 0.01) and at 500ms intervals (b= 0.36, t(50) = 2.69, p< 0.01)
at baseline were predictive of total change in percentages in self-
reported self-efficacy to abstain from cocaine. CT of the Spatial
Tapping Task at 300ms intervals were also found to be predictive
of total change in cocaine self-efficacy (b = 0.31, t(50) = −2.62,
p = 0.01). Although not significant, Asynchrony of the Spatial
Tapping Task at 300ms interval condition occurred in 17 of the
top 20 best predictor models.
Prognostic Value of Motor Timing in Relapse
Prediction
Of the 74 participants, 44 were interviewed at 12-months post-
discharge, with 30 participants lost to follow up. Data from
36 participants with the least missing data were used for these
analyses. Of these 36, 6 relapsed while all other participants
remained abstinent of drugs and alcohol use post-discharge. The
small sample, and limited power, precluded analysis of motor
timing predictors of relapse.
DISCUSSION
The main aim was to test for prognostic indicators in SUD
with regard to motor timing (measured in terms of treatment
response). We expected that motor coordination and planning
abilities, synchronization abilities and decision making would
be prognostic of treatment outcomes (self-perceived efficacy to
abstain from substances) at 8 weeks and relapse at 12 months
(yes/no). With regard to treatment outcomes, we found that
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TABLE 1 | Demographic and clinical characteristics of the separate groups and all patients combined.
N = 74 Alcohol Cocaine Alcohol/cocaine All patients
n = 25 n = 24 n = 25 n = 74
M SD M SD M SD M SD
Age 44.2 0.8 32.8 0.9 32.8 0.9 37.1 11.1
Alcohol use last 30 days 18.5 10.1 4 5.3 16.6 8.3 13.1 10.3
Alcohol quantity used last
30 days (units)
15.2 9.6 5.7 7.4 16.4 15.6 12.6 12.3
Cocaine use last 30 days 10.8 0.2 15.3 10.6 10.8 9.7 8.8 10.4
Cocaine quantity used last
30 days (grams)
0.04 0.1 3.2 3.4 1.3 1.4 1.5 2.5
AUDIT 25.3 8.9 8.2 5 24.6 7.5 19.6 10.7
DUDIT 7 8.1 31.5 7.6 28.6 8.8 23.6 13.2
Sheehan Disability Scale 16 7.1 21.4 6.3 17.4 9 18.6 7.8
Duration of Use 24.2 11.9 12.4 7.6 15.2 8.3 17.3 10.3
Age of first Use 20.5 9.3 20.9 5.5 17.3 4.1 19.6 6.8
Abstinence in days 16 14.1 14.6 12.1 14.2 10.43 14.9 12.2
GAF score at admission 52.8 6.9 51.5 11.7 52.5 7.5 52.3 8.9
Physical complaints 12.2 6.8 9.1 8.4 11.6 7.7 11 7.6
Craving (last 30 days) 6.7 3.3 7.9 4.2 7.8 4.2 7.5 3.9
Comorbid symptom severity 19.1 12.9 21 11.7 22.3 13.5 20.9 12.6
Results of separate groups; Intelligence: Nederlandse Leestest voor Volwassenen, AUDIT, Alcohol Use Disorder Identification Test; DUDIT, Drug Use Disorder Identification Test; Quality
of Life, Sheehan Disability Scale (SDS), GAF, Global Assessment of Functioning. Physical complaints MATE 5; Measurements in the Addictions for Triage and Evaluation, Physical
Complaints/health related symptoms (withdrawal) in the last 30 days; Craving MATE Q1 Measurements in the Addictions for Triage and Evaluation, Craving Scale regarding the last 30
days; Comorbid symptom severity MATE Q2, Measurements in the Addictions for Triage and Evaluation, Anxiety, Depression, Stress Scale last 30 days.
only the Spatial Tapping Task variables were predictive, and
explained 27% of alcohol use self-efficacy, and 25% of cocaine use
self-efficacy at discharge.
With regard to alcohol self-efficacy, SE (at ISI 300ms),
Asynchrony (at ISI 400ms) and IRI Errors (at ISI 500 and 700ms)
were predictive of self-perceived self-control to abstain from
alcohol use. With regard to cocaine self-efficacy, SE (at ISI 300
and 500ms) and CT (at ISI 300) were predictive of self-perceived
self-control to abstain from cocaine use. Due to the very small
number of participants who could be reached for follow-up, the
analyses of motor timing variables with regard to relapse at 12
months were omitted.
Interestingly the motor timing variables predicting cocaine
and alcohol self-efficacy were not the same. This may indicate
that there are different factors at play in different SUDs. The
only timing variable that was shared by both alcohol and cocaine
self-efficacy, and both at high tempi only, was SE on the Spatial
Tapping Task. Spatial abilities rely heavily on visual feedback and
patients may choose to be accurate above being correct which
could point to high compulsivity levels in patients. What the
predicting variables have in common is that they are all at high
tempi. This, again, may point to deficits that only manifest when
patients are under pressure, namely when the cognitive load goes
up, which is the case when time constraints are present, deficits
become apparent.
Another interesting assumption that can be made, based on
our findings, is the overlap between millisecond timing and
SUD deficits found in brain circuitry. The literature suggests
that the use of substances is associated with deficits in frontal
lobe and striatal functioning (Moselhy et al., 2001; Spronk
et al., 2013) through alteration in activation of the cortico-
limbic reward circuit (Welberg, 2011). Aspects of self-control,
delayed self-gratification, drive inhibition and anticipation of the
consequences all require the functional integrity of executive
pre-frontal cortical system (Lyvers, 2000). The breakdown of
orbitofrontal cortical communication may, in part, explain
the decrease in motivation and self-control experienced in
individuals with SUD (Dackis and O’Brien, 2001; Welberg,
2011). A recent study examining brain circuits involved in
time perception in the millisecond and second ranges probed
the role of the right supplementary motor area (SMA), the
right dorsolateral prefrontal cortex (dlPFC), and the cerebellum
(Méndez et al., 2017). Researchers temporarily altered activity
in healthy participants using transcranial magnetic stimulation
with the continuous Theta Burst Stimulation (cTBS) protocol.
Participants were tested on a temporal categorization task
before and after stimulation using intervals in the hundreds
and thousands of milliseconds ranges, as well as on a pitch
categorization task, used as a further control. Researchers looked
for changes in the Constant Error and the Relative Threshold,
which, respectively, reflect participants’ accuracy at setting an
interval that acts as a boundary between categories and their
sensitivity to interval duration. The researchers found that after
cTBS in all of the studied regions, the Relative Threshold, but
not the Constant Error, was affected, and only when hundreds
of milliseconds intervals were being categorized. Categorization
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TABLE 2 | Means and standard deviations of all motor tasks performances of patient group comparisons at baseline.
N = 74 Alcohol Cocaine Alcohol/cocaine All patients
n = 25 n = 24 n = 25 n = 74
M SD M SD M SD M SD
Go-nogo task Reaction time After go 0.66 0.51 0.42 0.04 0.51 0.18 0.51 0.01
After nogo 1.28 1.74 0.65 0.41 0.68 0.45 0.59 0.11
After nogo error 0.47 0.72 0.24 0.27 0.35 0.34 0.28 0.03
Finger Tapping Task Spontaneous ISI 494.85 140.58 401.05 99.26 451.53 120.90 451.53 120.90
Space Contact time (ms) 0.15 0.07 0.11 0.02 0.15 0.04 0.14 0.01
Spatial error (%) 11.3 3.3 13.7 3.7 11.7 2.7 12.2 0.41
Interval timing
Time
Asynchrony (%) −0.05 0.08 −0.03 0.06 −0.04 0.07 −0.04 0.01
IRI error (%) 6.7 2.3 7.1 3.2 6.8 2.8 7.1 0.18
Space Contact time (ms) 0.20 0.13 0.16 0.10 0.19 0.12 0.18 0.01
Spatial error (%) 11.4 3.5 11.6 3.2 11.1 3.2 11.6 0.22
Motor reaction task Movement
Initiation
1 target (ms) 0.40 0.07 0.41 0.08 0.40 0.06 0.40 0.01
2 targets (ms) 0.41 0.06 0.41 0.07 0.41 0.06 0.41 0.01
3 targets (ms) 0.40 0.05 0.41 0.07 0.40 0.03 0.40 0.01
All targets (ms) 0.40 0.06 0.41 0.06 0.40 0.07 0.40 0.01
Execution 1 target(ms) 0.36 0.09 0.38 0.09 0.43 0.13 0.39 0.01
2 targets(ms) 0.34 0.07 0.33 0.08 0.35 0.07 0.33 0.01
3 targets(ms) 0.34 0.07 0.31 0.07 0.33 0.07 0.32 0.01
All targets (ms) 0.35 0.08 0.36 0.10 0.33 0.08 0.35 0.01
of pitch, and thousands of milliseconds intervals were not
affected. These results suggest that the frontocerebellar circuit
is particularly involved in the estimation of intervals in the
hundreds of milliseconds range (Méndez et al., 2017). This
overlap in brain circuitry is affected by SUD, and motor timing
in the millisecond range may indeed hold promise for future
research focusing on biomarkers of SUD or indicators of the
severity of damage due to substance abuse.
One explanation of how motor timing deficits could
contribute directly to higher predisposition for relapse
in addiction is proposed by van Hoof (2002, 2003). The
model explains that the motoric mechanisms necessary
for grasping stationary and moving objects evolved and
matured to organize cognitive and emotional processes, such
as affiliation and intimidation. This organizational process
resulted in the capacity to organize intentional behavior van
Hoof (2002, 2003). Thus, mental representations of intended
or goal-action effects are responsible for the planning and
execution of appropriate movements required to achieve a
goal van Hoof (2002, 2003). Following this model, major
psychiatric disorders (e.g., schizophrenia and SUDs) may
be understood as manifestations of imbalances between an
automatic mode of action (referred to as the Drive Mechanism)
and a more cognitive-predictive mode of action (referred to
as the Guidance Mechanism, GM). This bimodal distribution
and evolutionary neurobiological model may provide a
useful pathogenic framework for the classification of major
psychiatric disorders, including SUDs van Hoof (2002, 2003),
and is tested as part of ongoing investigation (Young et al.,
2016).
Several limitations warrant mention. First, the high attrition
rate at the 12-month follow-up precluded the analysis of
predictors of relapse. The high rate of attrition may have
been mitigated by a shorter time to follow-up and the use
of face-to-face structured interviews rather than telephonic
interviews, supplemented by urine drug testing, to confirm
abstinence. Another limitation of the study was the use of a
subjective (self-reported self-efficacy) rather than more objective
measures available. As mentioned previously, among the more
objective measures are blood or urine tests. However not every
treatment setting allows for such measures to be used in a
useful way, requiring compromises to achieve the most valid
outcome possible. The validity of treatment outcome measures
in research depend on the type of treatment that patients are
undergoing. Even though lacking in objectivity, self-efficacy is
a subjective but an acceptable measure of treatment outcome
in our research setting. The study of treatment success in an
inpatient, closed-off, treatment setting precludes the assessment
of more objective outcomes, such as retention and abstinence.
Retention and abstinence are achieved by most in these settings,
which, if used as indicators would give the false impression
of greater treatment success. However, due to the subjective
nature of the outcome measures used the results should be
interpreted with care. Another limitation is that participants
without comorbid disorders and partcipants who did not use
psychotropic medications, at baseline, were included in the
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study, in order to avoid the confounding effects of comorbid
psychopathology and the effects of psychotropic medications
on motor timing performance. While this may reduce the
generalizability of these findings to patients with SUD and
comorbid psychopathology, even though we excluded patients
with a comorbid disorder at baseline, by the end of treatment
more than a third of the sample had been diagnosed with
comorbid disorders by their treating clinicians. This is not
unexpected given that (i) dual diagnosis is highly prevalent in
this population and (ii) when patients with SUD enter treatment,
it is often necessary to observe them after an extended period of
abstinence in order to distinguish between the effects of substance
withdrawal (which can be prolonged) and the symptoms of
comorbid mental disorders. In examining baseline predictors
of relapse, comorbid disorders were not adjusted for in the
analyses. This poses another question: is it the comorbid disorder
that may have had mediating effects? Another limitation is that
patients were in treatment for a period of 8 weeks. During this
period, they did not have access to their phones, ate healthily,
exercised, engaged in a structured programme in a supported
and therapeutic milieu, and did not face usual life stressors.
This “stability” of environment may have impacted on the
findings of our research. Research attempting to replicate the
results in outpatient populations may shed light on this possible
limitation.
Another limitation was that even though patients were
detoxified before arrival at the clinic some of them still tested
positive for substances. The clinic which Dutch patients were
admitted to is situated in South Africa; however, the long trip to
SA may have resulted in some patients using substances during
their travels. This means that a number of patients may have
undergone another withdrawal during their stay in the clinic.
Even though withdrawal and craving were well below cut-off
scores, some still experiencedmoderate to severe symptoms, such
as tremor which may have influenced performance on the motor
tasks. This limitation may have influenced the results of this
study.
Future research should focus on more diverse populations
with SUD and on inpatients and outpatients who are at different
points in their recovery process. A possible explanation for
the association between cognitive load and motor timing
abilities in SUD patients suggests that time constraints
and errors may be perceived as (more) stressful; they also
increase (perceived) cognitive load and subsequently lead
to loss of control over inhibition and rhythmic abilities.
To our knowledge, this is the first study to demonstrate
such an association, and based on our findings, replication
studies on motor timing abilities in SUD samples, their
prognostic value and their specificity for different SUD, are
warranted.
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